Anti-SDK1 monoclonal antibody
Anti-SDK1 antibody for FACS & in-vivo assay
Go to SDK1/SDK1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-MP1496-Ab-1/ GM-Tg-hg-MP1496-Ab-2 | Anti-Human SDK1 monoclonal antibody | Human |
GM-Tg-rg-MP1496-Ab-1/ GM-Tg-rg-MP1496-Ab-2 | Anti-Rat SDK1 monoclonal antibody | Rat |
GM-Tg-mg-MP1496-Ab-1/ GM-Tg-mg-MP1496-Ab-2 | Anti-Mouse SDK1 monoclonal antibody | Mouse |
GM-Tg-cynog-MP1496-Ab-1/ GM-Tg-cynog-MP1496-Ab-2 | Anti-Cynomolgus/ Rhesus macaque SDK1 monoclonal antibody | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-MP1496-Ab-1/ GM-Tg-felg-MP1496-Ab-2 | Anti-Feline SDK1 monoclonal antibody | Feline |
GM-Tg-cang-MP1496-Ab-1/ GM-Tg-cang-MP1496-Ab-2 | Anti-Canine SDK1 monoclonal antibody | Canine |
GM-Tg-bovg-MP1496-Ab-1/ GM-Tg-bovg-MP1496-Ab-2 | Anti-Bovine SDK1 monoclonal antibody | Bovine |
GM-Tg-equg-MP1496-Ab-1/ GM-Tg-equg-MP1496-Ab-2 | Anti-Equine SDK1 monoclonal antibody | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. | GM-Tg-hg-MP1496-Ab-1/ GM-Tg-hg-MP1496-Ab-2; GM-Tg-rg-MP1496-Ab-1/ GM-Tg-rg-MP1496-Ab-2; GM-Tg-mg-MP1496-Ab-1/ GM-Tg-mg-MP1496-Ab-2; GM-Tg-cynog-MP1496-Ab-1/ GM-Tg-cynog-MP1496-Ab-2; GM-Tg-felg-MP1496-Ab-1/ GM-Tg-felg-MP1496-Ab-2; GM-Tg-cang-MP1496-Ab-1/ GM-Tg-cang-MP1496-Ab-2; GM-Tg-bovg-MP1496-Ab-1/ GM-Tg-bovg-MP1496-Ab-2; GM-Tg-equg-MP1496-Ab-1/ GM-Tg-equg-MP1496-Ab-2 |
Products Name | Anti-SDK1 monoclonal antibody |
Format | mab |
Target Name | SDK1 |
Protein Sub-location | Transmembrane Protein |
Category of antibody | FACS/Biofunctional Antibody |
Derivation (species) | Mouse |
CH1+2+3 Isotype (Receptor identification) | IgG |
Type of Light Chain (VD-LC) | N/A |
Expression platform | Mammalian Expression |
Bioactivity validation | Binding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD). |
Tag | Fc |
Products description | Pre-made anti-SDK1 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
Target Antigen | Products Developing | Multi-species SDK1 VLP (virus-like particle) (Products Developing) |
Target information
Target ID | GM-MP1496 |
Target Name | SDK1 |
Gene ID | 221935,330222,304297,715160,489886,101094067,516333,100060475 |
Gene Symbol and Synonyms | 5330440E10,6720466O15Rik,RGD1560686,SDK1 |
Uniprot Accession | Q7Z5N4 |
Uniprot Entry Name | SDK1_HUMAN |
Protein Sub-location | Transmembrane Protein |
Category | |
Disease | N/A |
Gene Ensembl | ENSG00000146555 |
Target Classification | N/A |
The target: SDK1, gene name: SDK1, also named as . The protein encoded by this gene is a member of the immunoglobulin superfamily. The protein contains six immunoglobulin-like domains and thirteen fibronectin type III domains. Fibronectin type III domains are present in both extracellular and intracellular proteins and tandem repeats are known to contain binding sites for DNA, heparin and the cell surface. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2016].
About Gmab
GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.